HERON THERAPEUTICS, INC. /DE/ Number of Operating Segments
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Number of Operating Segments of 1 Segment for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-12.
Discontinued › Notes
us-gaap:NumberOfOperatingSegments · last filed 2024-03-12
- HERON THERAPEUTICS, INC. /DE/ number of operating segments for fiscal 2023 was 1.00 Segment.
| Period end | Number of Operating Segments 12 month |
|---|---|
| 2023-12-31 | 1.00 Segment 10-K · filed 2024-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |